AR050010A1 - Acido hialuronico reticulado soluble en agua, su procedimiento de preparacion, implanto que contiene dicho acido hialuronico reticulado, y su utilizacion - Google Patents
Acido hialuronico reticulado soluble en agua, su procedimiento de preparacion, implanto que contiene dicho acido hialuronico reticulado, y su utilizacionInfo
- Publication number
- AR050010A1 AR050010A1 ARP050103044A AR050010A1 AR 050010 A1 AR050010 A1 AR 050010A1 AR P050103044 A ARP050103044 A AR P050103044A AR 050010 A1 AR050010 A1 AR 050010A1
- Authority
- AR
- Argentina
- Prior art keywords
- hialuronic acid
- water soluble
- reticulated
- recycled
- acid
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 2
- 238000002513 implantation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 3
- 229920002674 hyaluronan Polymers 0.000 abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 abstract 3
- 102000015636 Oligopeptides Human genes 0.000 abstract 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 238000002316 cosmetic surgery Methods 0.000 abstract 1
- 239000007822 coupling agent Substances 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente tiene por objeto un ácido hialuronico reticulado que presenta solubilidad en agua y que es susceptible de ser obtenido por un procedimiento de preparacion que comprende la puesta en contacto en un medio acuoso de por lo menos un ácido hialuronico o una de sus sales, y por lo menos un agente reticulante que comprende por lo menos un oligopéptido o polipéptido que poseen por lo menos dos, de preferencia, por lo menos cinco unidades lisina, donde dicha puesta en contacto se efectua en presencia de por lo menos un agente de acoplamiento hidrosoluble y de por lo menos un catalizador. La presente se refiere también a un implanto que contiene dicho ácido hialuronico reticulado, y a su utilizacion en medicina humana o veterinaria, en particular en cirugía reparadora y/o estética.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0408199A FR2873379B1 (fr) | 2004-07-23 | 2004-07-23 | Procede de preparation d'acide hyaluronique reticule, acide hyaluronique reticule susceptible d'etre obtenu par ledit procede, implant contenant ledit acide hyaluronique reticule, et son utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR050010A1 true AR050010A1 (es) | 2006-09-20 |
Family
ID=34953044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103044 AR050010A1 (es) | 2004-07-23 | 2005-07-22 | Acido hialuronico reticulado soluble en agua, su procedimiento de preparacion, implanto que contiene dicho acido hialuronico reticulado, y su utilizacion |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR050010A1 (es) |
| FR (1) | FR2873379B1 (es) |
| WO (1) | WO2006021644A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101432311A (zh) * | 2006-02-28 | 2009-05-13 | 诺维信生物聚合物公司 | 透明质酸衍生物 |
| FR2908415B1 (fr) * | 2006-11-10 | 2009-01-23 | Abr Dev Sarl | Acide hyaluronique reticule et son procede de preparation |
| FR2909560B1 (fr) * | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
| JP5722217B2 (ja) | 2008-09-02 | 2015-05-20 | アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎ Ｈｏｌｄｉｎｇｓ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． | ヒアルロン酸および／またはその誘導体の糸、その作製方法、ならびにその使用 |
| US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
| HUE030138T2 (en) | 2010-03-22 | 2017-04-28 | Allergan Inc | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| AU2012262047A1 (en) | 2011-06-03 | 2014-01-16 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
| US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
| KR20220013588A (ko) * | 2011-09-14 | 2022-02-04 | 알러간, 인코포레이티드 | 잔주름 치료를 위한 진피 필러 조성물 |
| CA2858366C (en) * | 2011-12-08 | 2020-01-21 | Allergan Industrie, Sas | Optically transparent dermal filler compositions comprising hyaluronic acid crosslinked with diamines or multiamines |
| GB2501943B (en) * | 2012-05-10 | 2020-09-23 | Zeiss Carl Meditec Ag | Ophthalmic viscoelastic device |
| US20140315828A1 (en) | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
| WO2016051219A1 (en) | 2014-09-30 | 2016-04-07 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
| EP3653232A1 (en) | 2015-02-13 | 2020-05-20 | Allergan Industrie, SAS | Implants for sculpting, augmenting or correcting facial features such as the chin |
| AU2017315431B2 (en) | 2016-08-24 | 2020-06-25 | Allergan, Inc. | Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation |
| ES2898251T3 (es) * | 2017-07-26 | 2022-03-04 | Polypeptide Therapeutic Solutions S L | Polímeros entrecruzados compuestos de polisacáridos y poliaminoácidos, y usos de los mismos |
| FR3095206B1 (fr) * | 2019-04-17 | 2021-11-05 | Lab Vivacy | Procede de reticulation d’un polymere |
| CN111732741B (zh) * | 2020-06-24 | 2023-04-25 | 华熙生物科技股份有限公司 | 一种透明质酸与ε-聚赖氨酸交联的方法及所得复合交联物和应用 |
| CN115944553B (zh) * | 2022-12-07 | 2024-12-31 | 华熙生物科技股份有限公司 | 寡肽在提高交联透明质酸或其盐稳定性中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174999B1 (en) * | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
| FR2752843B1 (fr) * | 1996-08-30 | 1998-10-16 | Sod Conseils Rech Applic | Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique |
| FR2754828B1 (fr) * | 1996-10-23 | 1998-12-24 | Univ Toulouse | Structure membranaire artificielle, procede et polymere pour sa preparation, procede de preparation de ce polymere, particule et film comprenant cette structure |
| US6630457B1 (en) * | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| FR2793693A3 (fr) * | 1999-05-18 | 2000-11-24 | Martine Bulette | Prothese vasculaire impregnee par un biopolymere d'origine vegetale ou bacterienne et procede pour la realisation d'une telle prothese |
| RU2005102604A (ru) * | 2002-07-03 | 2005-09-10 | Перикор Сайенс, Инк. (Us) | Композиция гиалуроновой кислоты и способы применения |
| EP1535952B1 (en) * | 2003-11-28 | 2013-01-16 | Universite Louis Pasteur | Method for preparing crosslinked polyelectrolyte multilayer films |
-
2004
- 2004-07-23 FR FR0408199A patent/FR2873379B1/fr not_active Expired - Lifetime
-
2005
- 2005-07-12 WO PCT/FR2005/001808 patent/WO2006021644A1/fr not_active Ceased
- 2005-07-22 AR ARP050103044 patent/AR050010A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2873379B1 (fr) | 2008-05-16 |
| FR2873379A1 (fr) | 2006-01-27 |
| WO2006021644A1 (fr) | 2006-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102242894B1 (ko) | 이취 억제 방법 | |
| Mude et al. | Overview of in situ gelling injectable hydrogels for diabetic wounds | |
| DE69628783D1 (de) | Hydrogelbildende, selbst-solvatisierende, absorbierbare Polyestercopolymere sowie Verfahren zu deren Verwendung | |
| Kim et al. | Bilateral blindness after filler injection | |
| ES2062450T3 (es) | Sales metalicas bivalentes del acido n,n-di(carboximetil)-2-amino-3-ciano-4-carboximetil-5-carboxi-tiofeno y su procedimiento de preparacion. | |
| ES2065885T3 (es) | Metodo de imprimacion de tejido duro. | |
| WO2006041942A3 (en) | Ocular delivery of polymeric delivery formulations | |
| JP2018504167A5 (es) | ||
| ES2696282T3 (es) | Composiciones farmacéuticas que comprenden colágeno y hialuronato de sodio. | |
| BR0207249A (pt) | Método para tratar uma doença, uma deformação ou um distúrbio de um paciente humano ou veterinário | |
| DE69929278D1 (de) | Hydrogelbildende, selbst-solvatisierende, absorbierbare Polyestercopolymere sowie Verfahren zu deren Verwendung | |
| ES2073583T3 (es) | Dispositivo para irradiar rayos laser. | |
| BRPI0508349B8 (pt) | método de determinar um formato de tratamento refrativo para melhorar uma condição de visão em um paciente, e, sistema para gerar um formato de tratamento refrativo para melhorar a condição de visão em um olho de um paciente | |
| CL2004001642A1 (es) | Uso de un hidrolizado de proteina de pescado util para elaborar composiciones farmaceuticas y nutricionales, metodo de elaboracion de dicho hidrolizado. | |
| DE69029257D1 (de) | Anordnung zur bestrahlung von laserstrahlen | |
| DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
| ES2194727T3 (es) | Estructuras tridimensionales que contienen derivados del acido hialuronico obtenidos por la tecnica del antidisolvente supercritico. | |
| Ghandforoushan et al. | Injectable and adhesive hydrogels for dealing with wounds | |
| DK1450771T3 (da) | Farmaceutiske præparater til behandling af hudlæsioner og slimhinder og fremgangsmåder og kits til anvendelse heraf | |
| BR0016304A (pt) | Formulação de solução aquosa de interferon estável, método de preparação e usos para a mesma | |
| US20180161362A1 (en) | Controllably Degradable Compositions and Methods | |
| DE60011062D1 (de) | Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel | |
| FR2819814B1 (fr) | Composition gelifiable biocompatible et implantable | |
| CN110075345A (zh) | 适用于胃窥镜喷涂到胃损伤黏膜表面的双组分自粘性胃黏膜保护胶及其应用 | |
| KR102020119B1 (ko) | 레이저 치료가 가능한 창상피복재 및 이의 제조에 이용되는 의료용 삽입기구 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |